FOXO3 and breast cancer: A better understanding of the mechanism by which Akt and FOXO3a are regulated, as well as their roles in cancer progression, drug sensitivity and resistance, may turn these proteins into crucial therapeutic targets and prognostic markers for breast cancer and other malignancies.